Hideki Shimomura

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

Sonia S. Anand, Jackie Bosch, John W. Eikelboom et al. · The Lancet · 2017 · 855 citations · Full text

Thrombosis, Cardiovascular Disease, Stroke +13

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

Stuart J. Connolly, John W. Eikelboom, Jackie Bosch et al. · The Lancet · 2017 · 749 citations · Full text

Thrombosis, Cardiovascular Disease, Atherosclerosis +12

Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention

Kenichi Tsujita, Seigo Sugiyama, Hitoshi Sumida et al. · Journal of the American College of Cardiology · 2015 · 432 citations

Percutaneous Coronary Intervention, Health Policy, Cardiovascular Disease +12

The Changing Landscape for Stroke Prevention in AF

Menno V. Huisman, Kenneth J. Rothman, Miney Paquette et al. · Journal of the American College of Cardiology · 2017 · 276 citations · Full text

Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients

Taisei Mushiroda, Yozo Ohnishi, Susumu Saito et al. · Journal of Human Genetics · 2006 · 143 citations · Full text

Thrombosis, Warfarin Dose Requirements, Cardiovascular Disease +9